Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
86.3M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
19.3M
-
Shares change
-
-726K
-
Total reported value, excl. options
-
$61M
-
Value change
-
-$2.35M
-
Put/Call ratio
-
0.07
-
Number of buys
-
23
-
Number of sells
-
-29
-
Price
-
$3.16
Significant Holders of Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC) as of Q2 2023
68 filings reported holding IPSC - Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2023.
Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.3M shares
of 86.3M outstanding shares and own 22.35% of the company stock.
Largest 10 shareholders include FMR LLC (5.17M shares), Casdin Capital, LLC (3.21M shares), BlackRock Inc. (1.62M shares), DAFNA Capital Management LLC (1.31M shares), BAKER BROS. ADVISORS LP (1.15M shares), VANGUARD GROUP INC (1.15M shares), Avidity Partners Management LP (1.11M shares), Deep Track Capital, LP (1.02M shares), FEDERATED HERMES, INC. (614K shares), and STATE STREET CORP (455K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.